The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pramipexole Mylan 0.088 mg tablets

0.088 milligram(s) Tablet

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/138/001

Main Information

Trade NamePramipexole Mylan 0.088 mg tablets
Active SubstancesPramipexole
Strength0.088 milligram(s)
Dosage FormTablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/138/001

Group Information

ATC CodeN04BC Dopamine agonists
N04BC05 pramipexole

Status

Authorised/WithdrawnAuthorised
Licence Issued19/11/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back